Press Article Excerpt

January 19, 2008

Star-Ledger (NJ), "New label for Ortho Evra birth control patch"

The Food and Drug Administration yesterday approved an updated label for Johnson & Johnson's Ortho Evra birth control patch that gives heightened emphasis to the risk of serious blood clots some women could face.

The label change was prompted by a study conducted by the Boston Collaborative Drug Surveillance Program, which found that women who used the patch were at higher risk of blood clots that form in the legs and lungs, a condition known as venuous thromboembolism. An earlier study by the group found no difference in the risk of clots between women who used the patch and those who took birth control pills.

Women who use the patch face a 60 percent higher overall exposure to estrogen than those who use oral contraceptives, according to the FDA. Higher estrogen exposure has been linked to clot formation in some women. Those risks were included in the existing label for the patch, but are now disclosed in bold lettering.

Learn more about the rights of women who have been injured or died as a result of taking Ortho Evra.

Guidant, Ortho Evra, Auto Switch Fires
Car Accidents, Aviation Law, 15-Passenger
Van Accidents, SUV Rollover Crashes
Lieff Cabraser Heimann & Bernstein, LLP

Additional Lieff Cabraser Information: Lieff Cabraser Heimann & Bernstein, LLP, with offices in San Francisco, New York and Nashville, is one of the largest law firms in the United States that represents only plaintiffs. We have been nationally recognized for our representation of victims of dangerous and defective medical products. We are representing Ortho Evra birth control patch patients in individual peronal injury lawsuits.

Our clients come from across America, including the states of Alaska, Alabama, Arkansas, Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Washington, Wisconsin, West Virginia and Wyoming. Learn more about our firm.

Disclaimer: The hiring of legal professionals is an important decision that should not be based on advertising alone. Please read our attorney advertising disclaimer.

Trademark Notice: Ortho Evra is a trademark of Ortho-McNeil Pharmaceuticals Inc. and is used for product identification purposes only. The law firm of Lieff Cabraser Heimann & Bernstein, LLP, is in no way affiliated with Ortho-McNeil Pharmaceuticals Inc. or its subsidiary, Ortho Women's Health.